White Sands Pharma Overview

  • Founded
  • 2014
  • Status
  • Private
  • Employees
  • 8
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $4.3M
Latest Deal Amount

White Sands Pharma General Information


Developer of novel treatments for Irritable Bowel Syndrome.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Healthcare Services
Primary Office
  • 401 South Cedar Street
  • Little Rock, AR 72205
  • United States
+1 (941) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

White Sands Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 01-Mar-2018 $4.3M 00.00 Completed Startup
To view White Sands Pharma’s complete valuation and funding history, request access »

White Sands Pharma Executive Team (1)

Name Title Board Seat Contact Info
Michael Geranen Chief Executive Officer & Manager
To view White Sands Pharma’s complete executive team members history, request access »

White Sands Pharma Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial